UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000062038 |
|---|---|
| Receipt number | R000070920 |
| Scientific Title | The Effect of Ingestion of Ginkgo Biloba-derived Flavonoid Glycosides and Terpene Lactones on Cognitive Function: A Systematic Review. |
| Date of disclosure of the study information | 2026/06/25 |
| Last modified on | 2026/06/24 09:55:49 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The Effect of Ingestion of Ginkgo Biloba-derived Flavonoid Glycosides and Terpene Lactones on Cognitive Function: A Systematic Review.
Acronym
Effect of Ginkgo Biloba-derived Flavonoid Glycosides and Terpene Lactones on Cognitive Function: A Systematic Review.
Scientific Title
The Effect of Ingestion of Ginkgo Biloba-derived Flavonoid Glycosides and Terpene Lactones on Cognitive Function: A Systematic Review.
Scientific Title:Acronym
Effect of Ginkgo Biloba-derived Flavonoid Glycosides and Terpene Lactones on Cognitive Function: A Systematic Review.
Region
| Japan |
Condition
Condition
Healthy adults aged 40 years or older.
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the effects of Ginkgo biloba-derived flavonoid glycosides and terpene lactones intake on cognitive function.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Cognitive function (memory and judgment accuracy)
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 40 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Healthy adults aged 40 and older with no diagnosed diseases.
Key exclusion criteria
Individuals with diseases, pregnant women (including those planning to become pregnant), and lactating women.
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Toshiharu |
| Middle name | |
| Last name | Miyai |
Organization
Yamada Bee Company, Inc.
Division name
Dietary Supplement Development Section.
Zip code
708-0393
Address
194 Ichiba, Kagamino-cho, Tomata-gun, Okayama, Japan.
TEL
0868-54-5138
tm1614@yamada-bee.com
Public contact
Name of contact person
| 1st name | Aika |
| Middle name | |
| Last name | Ohnishi |
Organization
Yamada Bee Company, Inc.
Division name
Dietary Supplement Development Section.
Zip code
708-0393
Address
194 Ichiba, Kagamino-cho, Tomata-gun, Okayama, Japan.
TEL
0868-54-5138
Homepage URL
ao2179@yamada-bee.com
Sponsor or person
Institute
Yakujihou Marketing Jimusho Co., Ltd.
Institute
Department
Personal name
Funding Source
Organization
Yamada Bee Company, Inc.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
N/A
Address
N/A
Tel
0868-54-5138
ao2179@yamada-bee.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 06 | Month | 25 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 06 | Month | 19 | Day |
Date of IRB
Anticipated trial start date
| 2026 | Year | 06 | Month | 26 | Day |
Last follow-up date
| 2026 | Year | 08 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This research review will be conducted in accordance with PRISMA 2020.
Management information
Registered date
| 2026 | Year | 06 | Month | 24 | Day |
Last modified on
| 2026 | Year | 06 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070920
